[Technical and biological evolution of medically assisted procreation (MAP)].
Compared to IUI (to which one knows that an ovulation induction must not be associated and where 6 cycles must not be exceeded), in vitro fertilization has undergone an important evolution. It has now become ambulatory. Its evolution has been marked by the use of LH-RH agonists, the vaginal route for the echographic puncture and freezing of the embryos. The two progresses expected are: in the short term, the mastering of the retrograde catheterization of the tube, to enable the embryo replacement in sterilities of healthy tubes and, in middle term, a better assessment of the quality of the conceptus to carry out a selective embryo transfer and to reduce the rate of multiple pregnancies.
Camier
B
B
CHRU, Centre de Gynécologie-Obstétrique, Amiens.
D002996:Clomiphene / Q000627:therapeutic use; D004624:Embryo Transfer; D005260:Female; D005307:Fertilization in Vitro; D005640:Follicle Stimulating Hormone / Q000097:blood; D005615:Freezing; D006801:Humans; D007231:Infant, Newborn; D007315:Insemination, Artificial; D007986:Luteinizing Hormone / Q000097:blood; D008297:Male; D009865:Oocytes; D011247:Pregnancy; D011271:Pregnancy, Ectopic; D011272:Pregnancy, Multiple
D002996:Clomiphene; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone
Evolution technique et biologique des procréations médicalement assistées (PMA).